HALEOSLABS logo

HALEOSLABS (HALEOSLABS)

Market Closed
5 Aug, 10:00
XNSE XNSE
1,427. 70
-111.9
-7.2681%
4.3B Market Cap
- P/E Ratio
- Div Yield
2,482 Volume
- Eps
1,539.6
Previous Close
Add Transaction
Day Range
1,400 1,599.4
Year Range
1,091.1 1,774
Want to track HALEOSLABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HALEOSLABS closed today lower at ₹1,427.7, a decrease of -7.2681% from yesterday's close, completing a monthly decrease of -7.3644% or -₹113.5. Over the past 12 months, HALEOSLABS stock gained 10.5801%.
HALEOSLABS is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

HALEOSLABS Chart

People also search for

GPT Healthcare Ltd.
164.7
+1.5664%
Sastasundar Ventures Ltd.
306.2
-3.3154%
Max India Limited
171.22
-0.3376%
Kokuyo Camlin Ltd.
88.28
+3.6759%
Sterling Tools Ltd.
251.9
+0.0993%

HALEOSLABS (HALEOSLABS) FAQ

What is the stock price today?

The current price is ₹1,427.70.

On which exchange is it traded?

HALEOSLABS is listed on XNSE.

What is its stock symbol?

The ticker symbol is HALEOSLABS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.3B.

Has HALEOSLABS ever had a stock split?

No, there has never been a stock split.

HALEOSLABS Profile

Biotechnology Industry
Healthcare Sector
- CEO
XNSE Exchange
INE320X01016 ISIN
India Country
592 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Haleos Labs Limited is a prominent manufacturer of active pharmaceutical ingredients (API) and intermediates located in India. The company has established itself in the pharmaceutical industry by providing a wide range of high-quality APIs and intermediates intended for various therapeutic areas. Founded in 1990 and formerly known as SMS Lifesciences India Limited, the company underwent a rebranding to Haleos Labs Limited in August 2025. Based in Hyderabad, India, Haleos Labs Limited exemplifies a commitment to excellence in pharmaceutical manufacturing and exports its products to international markets, contributing to global healthcare solutions.

Products and Services

  • Anti-ulcer APIs

    Products designed to alleviate symptoms of ulcer conditions, ensuring effective treatment options for patients suffering from peptic ulcers.

  • Anti-migraine APIs

    A range of formulations aimed at providing relief from migraine attacks, helping patients manage this debilitating condition.

  • Anti-hypertensive APIs

    Ingredients used in medications that help to lower blood pressure, crucial in managing hypertension effectively in patients.

  • Erectile Dysfunction APIs

    Active ingredients that provide solutions for erectile dysfunction, improving sexual health and well-being for men.

  • Anti-cancer APIs

    Formulations aimed at combating various forms of cancer, contributing to effective treatment regimens tailored for oncology patients.

  • Antifungal APIs

    Products focused on the treatment of fungal infections, important for maintaining overall health in patients affected by these conditions.

  • Anti-obesity APIs

    Ingredients that assist in weight management and obesity treatment, promoting healthier living through dietary and pharmacological interventions.

  • Anti-emetic APIs

    Active ingredients used to prevent or treat nausea and vomiting, essential for patients undergoing chemotherapy or surgical procedures.

  • Anti-depressant APIs

    Formulations that assist in the management of depression, providing critical support for mental health care.

  • Anti-worm APIs

    Active ingredients targeted at treating worm infestations, important for maintaining health, especially in affected populations.

  • Anti-infective APIs

    Products designed to combat various infections, essential for effective treatment and disease prevention in patients.

  • Anti-gout APIs

    Ingredients used in the management of gout, providing relief from pain and inflammation associated with this condition.

  • Anti-convulsant APIs

    Formulations aimed at controlling seizures and managing epilepsy, ensuring safety and efficacy for patients with neurological disorders.

  • Antiviral APIs

    Active ingredients developed to manage viral infections, playing a crucial role in contemporary healthcare, especially amid rising viral challenges.

  • Anesthesia APIs

    Products that facilitate patient comfort during surgical procedures, ensuring safety and efficacy in anesthesia management.

  • Antihistamine APIs

    Ingredients that provide relief from allergic reactions, improving quality of life for individuals sensitive to allergens.

  • Diuretics APIs

    Active ingredients used in medications that promote diuresis, vital for managing conditions like hypertension and edema.

  • Hair Loss APIs

    Products aimed at preventing or treating hair loss, contributing to solutions for those experiencing hair thinning and baldness.

  • Ophthalmic APIs

    Active ingredients designed for treating eye ailments, ensuring effective interventions for ocular health and vision care.

Contact Information

Address: Plot No. 19-III
Phone: 91 40 6628 8888